It avoids medical claims or usage guidance and instead focuses on presenting investigational context in a clean, scannable format suitable for research-focused audiences
The compound did not advance to Phase 3 because the efficacy was insufficient for drug approval
In the absence of coenzyme B 12 , tetrahydrofolate cannot be regenerated from its inactive storage form, 5- methyltetrahydrofolate, and a functional folate deficiency occurs
Neurological Health With neuroprotective properties, BPC-157 is shown in animal models to reduce damage due to central nervous system injuries and strokes
General Symptoms Some patients may report headache, fatigue, flushing, dizziness, nausea, stomach discomfort or changes in how they feel during treatment